Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles.

The escalation of multidrug-resistant pathogens has created a dire need to develop novel ways of addressing this global therapeutic challenge. Because of their antimicrobial activities, the combination of antimicrobial peptides (AMPs) and nanoparticles is a promising tool with which to kill drug-resistant pathogens. In recent years, several studies using AMP-nanoparticle conjugates, especially metallic nanoparticles, as potential antimicrobial agents against drug-resistant pathogens have been published. Among these, antimicrobial-peptide-conjugated gold nanoparticles (AMP-AuNPs) are particularly attractive because of the nontoxic nature of gold and the possibility of fine-tuning the AMP-NP conjugation chemistry. The following review discusses recent developments in the synthesis and antimicrobial activity studies of AMP-AuNPs. The classification of AMPs, their mechanisms of action, methods used for functionalizing AuNPs with AMPs, and the antimicrobial activities of the conjugates are discussed.

[1]  I. Toth,et al.  Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products , 2011, Medicinal research reviews.

[2]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  V. Manchanda,et al.  Multidrug Resistant Acinetobacter , 2010, Journal of global infectious diseases.

[4]  V. Vishwakarma,et al.  Safety and Risk Associated with Nanoparticles - A Review , 2010 .

[5]  Maria Luisa Mangoni,et al.  Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a(1-21)NH2 as a reliable strategy for antipseudomonal drugs. , 2017, Acta biomaterialia.

[6]  S. Gambhir,et al.  Noninvasive molecular imaging of small living subjects using Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[7]  J. Vederas,et al.  Synthesis and Structure − Activity Relationship Studies of N ‐ Terminal Analogues of the Antimicrobial Peptide Tridecaptin A 1 , 2014 .

[8]  S. Assinder,et al.  Mathematical model of β-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released β-lactamases , 1996 .

[9]  Younan Xia,et al.  Gold Nanomaterials at Work in Biomedicine. , 2015, Chemical reviews.

[10]  Katsumi Matsuzaki,et al.  Control of cell selectivity of antimicrobial peptides. , 2009, Biochimica et biophysica acta.

[11]  Dong Choon Hyun,et al.  Engineered nanoparticles for drug delivery in cancer therapy. , 2014, Angewandte Chemie.

[12]  Ildinete Silva-Pereira,et al.  Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance , 2013, Front. Microbiol..

[13]  Vladimir P Zharov,et al.  Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. , 2006, Biophysical journal.

[14]  Jong-kook Lee,et al.  Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium. , 2016, Biomaterials.

[15]  Kai Hilpert,et al.  Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides , 2009, Antimicrobial Agents and Chemotherapy.

[16]  S. White,et al.  'Detergent-like' permeabilization of anionic lipid vesicles by melittin. , 2001, Biochimica et biophysica acta.

[17]  V. Rotello,et al.  Cell surface-based sensing with metallic nanoparticles. , 2015, Chemical Society reviews.

[18]  P. Stewart,et al.  Mechanisms of antibiotic resistance in bacterial biofilms. , 2002, International journal of medical microbiology : IJMM.

[19]  Ali Akbar Pourfatollah,et al.  Various methods of gold nanoparticles (GNPs) conjugation to antibodies , 2016 .

[20]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[21]  R. Hancock,et al.  Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides , 1999, Infection and Immunity.

[22]  M. Eblan,et al.  Clinical Translation of Nanomedicine. , 2015, Chemical reviews.

[23]  J. Odeberg,et al.  FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  U. Heinzmann,et al.  Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. , 2001, Environmental health perspectives.

[25]  K. Brogden,et al.  Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? , 2011, International journal of antimicrobial agents.

[26]  R. Hancock,et al.  Interaction of Cationic Peptides with Lipoteichoic Acid and Gram-Positive Bacteria , 1999, Infection and Immunity.

[27]  T. Chakraborty,et al.  Towards the synthesis of sugar amino acid containing antimicrobial noncytotoxic CAP conjugates with gold nanoparticles and a mechanistic study of cell disruption. , 2011, Organic & biomolecular chemistry.

[28]  Francesco Stellacci,et al.  Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. , 2008, Nature materials.

[29]  K. Lohner New strategies for novel antibiotics: peptides targeting bacterial cell membranes. , 2009, General physiology and biophysics.

[30]  Joel A. Swanson,et al.  Shaping cups into phagosomes and macropinosomes , 2008, Nature Reviews Molecular Cell Biology.

[31]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[32]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .

[33]  L. Yang,et al.  Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.

[34]  Liming Wang,et al.  Cytotoxic Potential of Silver Nanoparticles , 2014, Yonsei medical journal.

[35]  Peter Wipf,et al.  Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.

[36]  Laetitia Gonzalez,et al.  Genotoxicity of engineered nanomaterials: A critical review , 2008 .

[37]  M. Casu,et al.  Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties , 2010, Peptides.

[38]  B. Roelofsen,et al.  The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. , 1973, Biochimica et biophysica acta.

[39]  L. Shao,et al.  The antimicrobial activity of nanoparticles: present situation and prospects for the future , 2017, International journal of nanomedicine.

[40]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[41]  Sabine Neuss,et al.  Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. , 2009, Small.

[42]  T. Miyata,et al.  Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. , 1988, The Journal of biological chemistry.

[43]  Y. Shai,et al.  Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. , 1992, Biochemistry.

[44]  K. Sokolov,et al.  Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. , 2007, Nano letters.

[45]  J. A. Salkeld,et al.  Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection. , 2015, The Journal of hospital infection.

[46]  Chen Zhou,et al.  Renal clearable inorganic nanoparticles: A new frontier of bionanotechnology , 2013 .

[47]  I. Neundorf,et al.  Design and Application of Antimicrobial Peptide Conjugates , 2016, International journal of molecular sciences.

[48]  K. Ulbrich,et al.  Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. , 2016, Chemical reviews.

[49]  H. Vogel,et al.  The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.

[50]  Pawel L Urban,et al.  Nanoparticles: their potential toxicity, waste and environmental management. , 2009, Waste management.

[51]  A. Decho,et al.  Inorganic nanoparticles engineered to attack bacteria. , 2015, Chemical Society reviews.

[52]  Meng Wang,et al.  Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. , 2006, Toxicology letters.

[53]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Gan-Moog Chow,et al.  In vivo toxic studies and biodistribution of near infrared sensitive Au–Au2S nanoparticles as potential drug delivery carriers , 2008, Journal of materials science. Materials in medicine.

[55]  S. Hua Lipid-based nano-delivery systems for skin delivery of drugs and bioactives , 2015, Front. Pharmacol..

[56]  S. Mitragotri,et al.  Nanoparticles in the clinic , 2016, Bioengineering & translational medicine.

[57]  L. Gentilucci,et al.  Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. , 2010, Current pharmaceutical design.

[58]  Y. Shai,et al.  Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. , 2000, Biochemistry.

[59]  J. Reichert,et al.  Future directions for peptide therapeutics development. , 2013, Drug discovery today.

[60]  Xinyuan Zhu,et al.  Phospholipid-assisted synthesis of size-controlled gold nanoparticles , 2007 .

[61]  J. Rädler,et al.  Controlled nanometric phase transitions of phospholipid membranes by plasmonic heating of single gold nanoparticles. , 2009, Nano letters.

[62]  T. Ganz Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[63]  F. Masood,et al.  Polymeric nanoparticles for targeted drug delivery system for cancer therapy. , 2016, Materials science & engineering. C, Materials for biological applications.

[64]  Ameer Azam,et al.  Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study , 2012, International journal of nanomedicine.

[65]  Anirban Bhunia,et al.  Enhanced stability and activity of an antimicrobial peptide in conjugation with silver nanoparticle. , 2016, Journal of colloid and interface science.

[66]  H. G. Boman,et al.  Ascaris nematodes from pig and human make three anti-bacterial peptides: isolation of cecropin P1 and two ASABF peptides , 2003, Cellular and Molecular Life Sciences CMLS.

[67]  H Lecar,et al.  Electrically gated ionic channels in lipid bilayers , 1977, Quarterly Reviews of Biophysics.

[68]  Rodolfo Miranda,et al.  Engineering Iron Oxide Nanoparticles for Clinical Settings , 2014, Nanobiomedicine.

[69]  K. Rumbaugh,et al.  One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model. , 2016, Biomaterials.

[70]  Ali Pourmand,et al.  Current Opinion on Nanotoxicology , 2012, DARU Journal of Pharmaceutical Sciences.

[71]  Chun-Ming Huang,et al.  Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections. , 2009, Current drug metabolism.

[72]  Dakrong Pissuwan,et al.  The forthcoming applications of gold nanoparticles in drug and gene delivery systems. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[73]  Ekambaram Perumal,et al.  Metal oxide nanoparticles as antimicrobial agents: a promise for the future. , 2017, International journal of antimicrobial agents.

[74]  M. Marahiel,et al.  The Structural Diversity of Acidic Lipopeptide Antibiotics , 2009, Chembiochem : a European journal of chemical biology.

[75]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[76]  A. Ulrich,et al.  Antibiotic gold: tethering of antimicrobial peptides to gold nanoparticles maintains conformational flexibility of peptides and improves trypsin susceptibility. , 2017, Biomaterials science.

[77]  Y. Shai,et al.  Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .

[78]  J. Hamilton-miller,et al.  Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. , 1992, The Journal of antimicrobial chemotherapy.

[79]  Yingge Zhang,et al.  The application of carbon nanotubes in target drug delivery systems for cancer therapies , 2011, Nanoscale research letters.

[80]  Hongbin Li,et al.  Quantifying thiol–gold interactions towards the efficient strength control , 2014, Nature Communications.

[81]  Thomas Bjarnsholt,et al.  Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.

[82]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[83]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[84]  I. Sutherland,et al.  The biofilm matrix--an immobilized but dynamic microbial environment. , 2001, Trends in microbiology.

[85]  Dar-Bin Shieh,et al.  Nanoshell Magnetic Resonance Imaging Contrast Agents , 2007, 2007 Digest of papers Microprocesses and Nanotechnology.

[86]  W. Chan,et al.  DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination , 2014, Nature nanotechnology.

[87]  Hui Zhang,et al.  Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. , 2007, Nano letters.

[88]  D. Dunn,et al.  Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa. , 2013, Biochimica et biophysica acta.

[89]  B. Bechinger,et al.  The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. , 1999, Biochimica et biophysica acta.

[90]  O. Shamova,et al.  Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics , 2011 .

[91]  A. Brandelli Nanostructures as promising tools for delivery of antimicrobial peptides. , 2012, Mini reviews in medicinal chemistry.

[92]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[93]  Jennifer K Barton,et al.  Biodegradable Plasmon Resonant Nanoshells , 2008, Advanced materials.

[94]  Meng Wang,et al.  Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. , 2008, Toxicology.

[95]  K. Lewis,et al.  Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.

[96]  M. Zasloff,et al.  Magainins: a new family of membrane-active host defense peptides. , 1990, Biochemical pharmacology.

[97]  Y. Shai,et al.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.

[98]  Xiangfang Zeng,et al.  Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal Industry , 2016, International journal of molecular sciences.

[99]  Xingyu Jiang,et al.  Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. , 2010, Journal of the American Chemical Society.

[100]  N. Fujii,et al.  An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.

[101]  W. H. Lewis Pinocytosis by Malignant Cells , 1937 .

[102]  R. Hancock,et al.  Antibacterial peptides for therapeutic use: obstacles and realistic outlook. , 2006, Current opinion in pharmacology.

[103]  Morteza Mahmoudi,et al.  Antibacterial properties of nanoparticles. , 2012, Trends in biotechnology.

[104]  H. Vogel,et al.  Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.

[105]  Brian F. G. Johnson,et al.  Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters , 2008, Nature.

[106]  T. Hoffmann,et al.  Peptide therapeutics: current status and future directions. , 2015, Drug discovery today.

[107]  P. Couvreur,et al.  Peptide conjugation: before or after nanoparticle formation? , 2014, Bioconjugate chemistry.

[108]  Avinash Sonawane,et al.  Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages , 2013, Antimicrobial Agents and Chemotherapy.

[109]  K. Matsuzaki Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.

[110]  V. Torchilin,et al.  Multifunctional polymeric micelles for delivery of drugs and siRNA , 2014, Front. Pharmacol..

[111]  Liangfang Zhang,et al.  Nanoparticle approaches against bacterial infections. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[112]  Yi Wang,et al.  A label-free biosensor based on gold nanoshell monolayers for monitoring biomolecular interactions in diluted whole blood. , 2008, Biosensors & bioelectronics.

[113]  R. Lehrer,et al.  Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins , 1993, FEBS letters.

[114]  Thomas Kelly,et al.  Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy , 2005, Lasers in surgery and medicine.

[115]  Seungpyo Hong,et al.  Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. , 2009, The journal of physical chemistry. B.

[116]  Tom P. Carberry,et al.  Dendrimers functionalized with membrane-interacting peptides for viral inhibition , 2013, International journal of nanomedicine.

[117]  C. R. Martin,et al.  Carbon nanotubule membranes for electrochemical energy storage and production , 1998, Nature.

[118]  Paul Stoodley,et al.  Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.

[119]  Arie V. Nieuw Amerongen,et al.  Antimicrobial Peptides: Properties and Applicability , 2001, Biological chemistry.

[120]  L. Mortelmans,et al.  Passage of Inhaled Particles Into the Blood Circulation in Humans , 2002, Circulation.

[121]  Maureen A Walling,et al.  Quantum Dots for Live Cell and In Vivo Imaging , 2009, International journal of molecular sciences.

[122]  M. Vaara Polymyxins and their novel derivatives. , 2010, Current opinion in microbiology.

[123]  R. Hancock,et al.  Mode of Action of the Antimicrobial Peptide Indolicidin* , 1996, The Journal of Biological Chemistry.

[124]  K. Hahm,et al.  Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. , 2005, Biochemistry.

[125]  R. Epand,et al.  Lipid domains in bacterial membranes and the action of antimicrobial agents. , 2009, Biochimica et biophysica acta.

[126]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[127]  Jean-François Lutz,et al.  Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne "click" chemistry. , 2008, Advanced drug delivery reviews.

[128]  Yibing Huang,et al.  Role of helicity of α-helical antimicrobial peptides to improve specificity , 2014, Protein & Cell.

[129]  David B Resnik,et al.  Ethics in nanomedicine. , 2007, Nanomedicine.

[130]  I. Chopra,et al.  The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? , 2007, The Journal of antimicrobial chemotherapy.

[131]  Ji-Xin Cheng,et al.  Gold Nanorods Mediate Tumor Cell Death by Compromising Membrane Integrity , 2007, Advanced materials.

[132]  C. Suri,et al.  Interaction of gold nanoparticles with protein: A spectroscopic study to monitor protein conformational changes , 2008 .

[133]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[134]  S. Pinto,et al.  High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells. , 2016, Acta biomaterialia.

[135]  M. Marahiel,et al.  Daptomycin, a Bacterial Lipopeptide Synthesized by a Nonribosomal Machinery* , 2010, The Journal of Biological Chemistry.

[136]  K. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[137]  M. Przybylski,et al.  Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. , 1990, The Journal of biological chemistry.

[138]  Itamar Willner,et al.  Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications. , 2004, Angewandte Chemie.

[139]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[140]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[141]  Jianping Xie,et al.  The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes. , 2013, Nanoscale.

[142]  Olivier Taboureau,et al.  Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus , 2005, Nature.

[143]  R. Landmann,et al.  Silver Coordination Polymers for Prevention of Implant Infection: Thiol Interaction, Impact on Respiratory Chain Enzymes, and Hydroxyl Radical Induction , 2010, Antimicrobial Agents and Chemotherapy.

[144]  D. Astruc,et al.  The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) “click” reaction and its applications. An overview , 2011 .

[145]  Keerti Jain,et al.  Dendrimer as nanocarrier for drug delivery , 2014 .

[146]  A. Obwegeser,et al.  Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages , 2008, Neurological research.

[147]  K. Gaus,et al.  Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. , 2009, Future medicinal chemistry.

[148]  Christopher J. White,et al.  Contemporary strategies for peptide macrocyclization. , 2011, Nature chemistry.

[149]  Anjan Kr Dasgupta,et al.  Cell selective response to gold nanoparticles. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[150]  Ramasamy Venkatesan,et al.  Vancomycin bound biogenic gold nanoparticles: A different perspective for development of anti VRSA agents , 2011 .

[151]  Craig A. Grimes,et al.  A review on highly ordered, vertically oriented TiO2 nanotube arrays: Fabrication, material properties, and solar energy applications , 2006 .

[152]  Yehuda Carmeli,et al.  Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact , 2006, Antimicrobial Agents and Chemotherapy.

[153]  Bing Xu,et al.  Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities , 2003 .

[154]  Jianqing Gao,et al.  Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity. , 2016, Biomaterials.

[155]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[156]  Y. Shai,et al.  Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. , 1997, Biochemistry.

[157]  Aswathy Ravindran,et al.  Biofunctionalized silver nanoparticles: advances and prospects. , 2013, Colloids and surfaces. B, Biointerfaces.

[158]  Miriam Rafailovich,et al.  Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents , 2011, Expert review of anti-infective therapy.

[159]  David Brown,et al.  The pulmonary toxicology of ultrafine particles. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[160]  R. Vitorino,et al.  Antimicrobial peptides: an alternative for innovative medicines? , 2015, Applied Microbiology and Biotechnology.

[161]  Agnes G Oomen,et al.  What do we (need to) know about the kinetic properties of nanoparticles in the body? , 2007, Regulatory toxicology and pharmacology : RTP.

[162]  C. Niemeyer REVIEW Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science , 2022 .

[163]  Wei-Yu Chen,et al.  Potent antibacterial nanoparticles for pathogenic bacteria. , 2015, ACS applied materials & interfaces.

[164]  Y. Barenholz Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[165]  Chuanqi Peng,et al.  Tailoring Renal Clearance and Tumor Targeting of Ultrasmall Metal Nanoparticles with Particle Density. , 2016, Angewandte Chemie.

[166]  Catherine J. Murphy,et al.  Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.

[167]  Hongtao Yu,et al.  Mechanisms of nanotoxicity: Generation of reactive oxygen species , 2014, Journal of food and drug analysis.

[168]  Bong‐Jin Lee,et al.  Antimicrobial peptides: therapeutic potentials , 2014, Expert review of anti-infective therapy.

[169]  Ling Yang,et al.  Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. , 2005, Toxicology letters.

[170]  M Laird Forrest,et al.  Clinical toxicities of nanocarrier systems. , 2008, Advanced drug delivery reviews.

[171]  Wei Qian,et al.  Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. , 2007, Nano letters.

[172]  K. Meng,et al.  Eukaryotic expression and antimicrobial spectrum determination of the peptide tachyplesin II. , 2008, Protein expression and purification.

[173]  M. Abdollahi,et al.  Different biokinetics of nanomedicines linking to their toxicity; an overview , 2013, DARU Journal of Pharmaceutical Sciences.

[174]  Frances Separovic,et al.  The antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism. , 2012, Physical chemistry chemical physics : PCCP.

[175]  Yoonkyung Park,et al.  Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties , 2015, Amino Acids.

[176]  Wenjing Zhang,et al.  Bacitracin-conjugated superparamagnetic iron oxide nanoparticles: synthesis, characterization and antibacterial activity. , 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.

[177]  A. Cameron,et al.  Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides. , 2015, Journal of medicinal chemistry.

[178]  Young Jik Kwon,et al.  "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[179]  J. Vederas,et al.  Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria. , 2015, Journal of medicinal chemistry.

[180]  C. Ricci,et al.  Antimicrobial Activity of Novel Dendrimeric Peptides Obtained by Phage Display Selection and Rational Modification , 2005, Antimicrobial Agents and Chemotherapy.

[181]  F. Tielens,et al.  AuS and SH Bond Formation/Breaking during the Formation of Alkanethiol SAMs on Au(111): A Theoretical Study , 2010 .

[182]  C. Deber,et al.  Basis for Selectivity of Cationic Antimicrobial Peptides for Bacterial Versus Mammalian Membranes* , 2005, Journal of Biological Chemistry.

[183]  Vincent M. Rotello,et al.  Applications of Nanoparticles in Biology , 2008 .

[184]  Kenneth Vecchio,et al.  Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. , 2011, Journal of the American Chemical Society.

[185]  M. Veerapandian,et al.  Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications , 2011, Applied Microbiology and Biotechnology.

[186]  K. Hahm,et al.  Cell selectivity of an antimicrobial peptide melittin diastereomer with D-amino acid in the leucine zipper sequence. , 2007, Journal of biochemistry and molecular biology.

[187]  Asad U. Khan,et al.  Nanoparticles vs. biofilms: a battle against another paradigm of antibiotic resistance , 2016 .

[188]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[189]  A. Thayer IMPROVING PEPTIDES: Small firms develop better PEPTIDE DRUG CANDIDATES to expand this pharmaceutical class and attract big pharma partners , 2011 .